159 related articles for article (PubMed ID: 35117919)
41. Super enhancers at the miR-146a and miR-155 genes contribute to self-regulation of inflammation.
Duan Q; Mao X; Xiao Y; Liu Z; Wang Y; Zhou H; Zhou Z; Cai J; Xia K; Zhu Q; Qi J; Huang H; Plutzky J; Yang T
Biochim Biophys Acta; 2016 Apr; 1859(4):564-71. PubMed ID: 26855180
[TBL] [Abstract][Full Text] [Related]
42. What are super-enhancers?
Pott S; Lieb JD
Nat Genet; 2015 Jan; 47(1):8-12. PubMed ID: 25547603
[TBL] [Abstract][Full Text] [Related]
43. Epigenomic features revealed by ATAC-seq impact transgene expression in CHO cells.
Lee Z; Raabe M; Hu WS
Biotechnol Bioeng; 2021 May; 118(5):1851-1861. PubMed ID: 33521928
[TBL] [Abstract][Full Text] [Related]
44. High-density P300 enhancers control cell state transitions.
Witte S; Bradley A; Enright AJ; Muljo SA
BMC Genomics; 2015 Nov; 16():903. PubMed ID: 26546038
[TBL] [Abstract][Full Text] [Related]
45. Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity.
Ooi WF; Xing M; Xu C; Yao X; Ramlee MK; Lim MC; Cao F; Lim K; Babu D; Poon LF; Lin Suling J; Qamra A; Irwanto A; Qu Zhengzhong J; Nandi T; Lee-Lim AP; Chan YS; Tay ST; Lee MH; Davies JO; Wong WK; Soo KC; Chan WH; Ong HS; Chow P; Wong CY; Rha SY; Liu J; Hillmer AM; Hughes JR; Rozen S; Teh BT; Fullwood MJ; Li S; Tan P
Nat Commun; 2016 Sep; 7():12983. PubMed ID: 27677335
[TBL] [Abstract][Full Text] [Related]
46. [Protocadherin 10 (PCDH10) inhibits the proliferation, invasion and migration ability of BXPC-3 pancreatic cancer cells].
Qiu C; Bu X; Hu D; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):163-7. PubMed ID: 26927373
[TBL] [Abstract][Full Text] [Related]
47. In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma.
Kumar R; Patiyal S; Kumar V; Nagpal G; Raghava GPS
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336658
[TBL] [Abstract][Full Text] [Related]
48. Stromal induction of BRD4 phosphorylation Results in Chromatin Remodeling and BET inhibitor Resistance in Colorectal Cancer.
Wang W; Tang YA; Xiao Q; Lee WC; Cheng B; Niu Z; Oguz G; Feng M; Lee PL; Li B; Yang ZH; Chen YF; Lan P; Wu XJ; Yu Q
Nat Commun; 2021 Jul; 12(1):4441. PubMed ID: 34290255
[TBL] [Abstract][Full Text] [Related]
49. Super enhancers - new analyses and perspectives on the low hanging fruit.
Hamdan FH; Johnsen SA
Transcription; 2018; 9(2):123-130. PubMed ID: 28980882
[TBL] [Abstract][Full Text] [Related]
50. BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance.
Tasdemir N; Banito A; Roe JS; Alonso-Curbelo D; Camiolo M; Tschaharganeh DF; Huang CH; Aksoy O; Bolden JE; Chen CC; Fennell M; Thapar V; Chicas A; Vakoc CR; Lowe SW
Cancer Discov; 2016 Jun; 6(6):612-29. PubMed ID: 27099234
[TBL] [Abstract][Full Text] [Related]
51. Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies.
Dębek S; Juszczyński P
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188697. PubMed ID: 35150791
[TBL] [Abstract][Full Text] [Related]
52. The expression of chemokine genes correlates with nuclear factor-kappaB activation in human pancreatic cancer cell lines.
Takaya H; Andoh A; Shimada M; Hata K; Fujiyama Y; Bamba T
Pancreas; 2000 Jul; 21(1):32-40. PubMed ID: 10881930
[TBL] [Abstract][Full Text] [Related]
53. Aberrant activation of CYR61 enhancers in colorectal cancer development.
Xie L; Song X; Lin H; Chen Z; Li Q; Guo T; Xu T; Su T; Xu M; Chang X; Wang LK; Liang B; Huang D
J Exp Clin Cancer Res; 2019 May; 38(1):213. PubMed ID: 31118064
[TBL] [Abstract][Full Text] [Related]
54. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
[TBL] [Abstract][Full Text] [Related]
55. The
Ri K; Kim C; Pak C; Ri P; Om H
Microrna; 2020; 9(1):64-69. PubMed ID: 30868974
[TBL] [Abstract][Full Text] [Related]
56. TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity.
Wang C; Jiang S; Zhang L; Li D; Liang J; Narita Y; Hou I; Zhong Q; Gewurz BE; Teng M; Zhao B
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167905
[TBL] [Abstract][Full Text] [Related]
57. Super-Enhancers at the Nanog Locus Differentially Regulate Neighboring Pluripotency-Associated Genes.
Blinka S; Reimer MH; Pulakanti K; Rao S
Cell Rep; 2016 Sep; 17(1):19-28. PubMed ID: 27681417
[TBL] [Abstract][Full Text] [Related]
58. Epstein-Barr virus oncoprotein super-enhancers control B cell growth.
Zhou H; Schmidt SC; Jiang S; Willox B; Bernhardt K; Liang J; Johannsen EC; Kharchenko P; Gewurz BE; Kieff E; Zhao B
Cell Host Microbe; 2015 Feb; 17(2):205-16. PubMed ID: 25639793
[TBL] [Abstract][Full Text] [Related]
59. Targeting of super-enhancers and mutant BRAF can suppress growth of BRAF-mutant colon cancer cells via repression of MAPK signaling pathway.
Nakamura Y; Hattori N; Iida N; Yamashita S; Mori A; Kimura K; Yoshino T; Ushijima T
Cancer Lett; 2017 Aug; 402():100-109. PubMed ID: 28576751
[TBL] [Abstract][Full Text] [Related]
60. Loss of synergistic transcriptional feedback loops drives diverse B-cell cancers.
Andrews JM; Pyfrom SC; Schmidt JA; Koues OI; Kowalewski RA; Grams NR; Sun JJ; Berman LR; Duncavage EJ; Lee YS; Cashen AF; Oltz EM; Payton JE
EBioMedicine; 2021 Sep; 71():103559. PubMed ID: 34461601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
